Robinhood stock today: HOOD slides after December trading snapshot and Goldman target trim
1 January 2026
1 min read

Robinhood stock today: HOOD slides after December trading snapshot and Goldman target trim

NEW YORK, January 1, 2026, 10:16 ET — Market closed

  • Robinhood shares last closed down about 2% on Dec. 31, ending 2025 on a softer note.
  • The company disclosed a December month-to-date trading snapshot that highlighted heavy options and prediction-market activity.
  • Goldman Sachs trimmed its price target while keeping a buy rating, according to MT Newswires.

Robinhood Markets Inc shares fell about 2% in the final U.S. session of 2025, closing at $113.10 on Wednesday, as U.S. markets shut on Thursday for the New Year’s Day holiday. Nasdaq

The drop put fresh attention on a late-December operating snapshot that offers investors an early read on customer trading activity ahead of the company’s quarterly results.

That matters because Robinhood’s revenue is closely tied to how much its customers trade, especially in options and crypto, where the company has historically generated more transaction-based revenue than in stocks.

In a release on Tuesday, Robinhood said December month-to-date equity notional trading volume was about $170 billion and options contracts traded were about 179 million. It also reported about $19 billion of crypto notional volume and roughly 2.6 billion event contracts traded through its prediction markets hub. MarketScreener

Notional volume is the total dollar value of trades executed over a period. An options contract typically represents 100 shares of the underlying stock, while event contracts are priced in pennies up to $1 and pay out $1 at settlement, the company said. MarketScreener

Robinhood said the figures were preliminary and unaudited, and that final results could change as it completes its financial close. MarketScreener

The stock also faced pressure after Goldman Sachs cut its price target on Robinhood to $164 from $167 and kept a buy rating, MT Newswires reported. Fidelity Fixed Income

The pullback came in a holiday-thin week for U.S. markets, when positioning can amplify moves in high-beta growth names. “The growth rates are going to converge between technology and everything else next year and the valuation gap is so wide,” said Mark Hackett, chief market strategist at Nationwide. Reuters

Robinhood’s shares have now slipped for two straight sessions, down from $115.45 on Dec. 30, according to Nasdaq data. Nasdaq

Investors will be watching whether the company’s early December activity—particularly the volume in options and prediction-market contracts—holds up through month-end and shows up in transaction revenue when results are reported.

Before markets reopen on Friday, traders will look for signs the stock can stabilize around the low-$110s area after the late-year slide, with Wednesday’s close near $113 keeping the recent downside pressure in view. Nasdaq

Macro data could also set the tone for risk appetite when trading resumes, including the next ISM manufacturing PMI release scheduled for Friday at 10:00 a.m. ET. YCharts

The next clear company catalyst is quarterly earnings. Robinhood has not announced a date, but Nasdaq estimates the company will report around Feb. 11, when investors will look for confirmation of trading momentum and any 2026 outlook commentary. Nasdaq

Stock Market Today

  • Investment Trust of India Shares Drop 10% This Week Amid Declining Earnings
    January 21, 2026, 9:09 PM EST. The Investment Trust of India Limited (NSE:THEINVEST) saw its stock fall 10% this past week, adding to a 39% drop over the last year, starkly underperforming the broader market gain of 4.6%. The company reported a 48% decline in earnings per share (EPS) over the past year. Despite this, the share price drop is smaller than the EPS decline, suggesting the market may have partly priced in the earnings trouble. Over three years, the stock remains 19% higher. Investors face caution with three risk warnings and the need to evaluate the firm's fundamentals closely before investing amidst ongoing challenges.
Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus
Previous Story

Disc Medicine (IRON) stock today: year-end rally keeps January FDA decision in focus

JPMorgan Chase stock today: JPM ends 2025 at $322 as Javice legal-fee fight resurfaces ahead of earnings
Next Story

JPMorgan Chase stock today: JPM ends 2025 at $322 as Javice legal-fee fight resurfaces ahead of earnings

Go toTop